A Prospective Study Evaluating IOP Changes after Switching from a Therapy with Prostaglandin Eye Drops Containing Preservatives to Nonpreserved Tafluprost in Glaucoma Patients
Figure 2
Graph showing IOP at each time point of the daily curve of each drug group. * from the comparison of tafluprost time point with the corresponding latanoprost and travoprost time point. **Values from the comparison between tafluprost and bimatoprost of each time point of the daily curve. (Curve of latanoprost, travoprost, and bimatoprost are prestudy, whereas curve of tafluprost is after dosing.)
